NMR studies of interactions of new CB2 cannabinoid receptor ligands with cyclodextrins hosts. Correlation with micellar electrokinetic chromatography and reversed phase high performance liquid chromatography-Reference-Cited by-同舟云学术

NMR studies of interactions of new CB2 cannabinoid receptor ligands with cyclodextrins hosts. Correlation with micellar electrokinetic chromatography and reversed phase high performance liquid chromatography

Published:2013-02-21 Issue:1-4 Volume:78 Page:265-274
ISSN:1388-3127
Container-title:Journal of Inclusion Phenomena and Macrocyclic Chemistry
language:en
Short-container-title:J Incl Phenom Macrocycl Chem

Author:

Azaroual Nathalie,Bakali Jamal El,Broc Delphine,Deghaye Carole,Farce Amaury,Chavatte Philippe,Millet Régis,Vaccher Claude,Lipka-Belloli Emmanuelle

Publisher

Springer Science and Business Media LLC

Subject

Condensed Matter Physics,General Chemistry,Food Science,Condensed Matter Physics,General Chemistry

Link

http://link.springer.com/content/pdf/10.1007/s10847-013-0295-0.pdf

Reference31 articles.

1. Massa, F., Marsicano, G., Hermann, H., Cannich, A., Monory, K., Cravatt, B.F., Ferri, G.L., Sibaev, A., Storr, M., Lutz, B.: The endogenous cannabinoid system protects against colonic inflammation. J. Clin. Invest. 113, 1202–1209 (2004)

2. Kimball, E.S., Schneider, C.R., Wallace, N.H., Hornby, P.J.: Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium. Am. J. Physiol. Gastrointest. Liver Physiol. 291, 364–371 (2006)

3. Singh, U.P., Singh, N.P., Singh, B., Price, R.L., Nagarkatti, M., Nagarkatti, P.S.: Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis. Toxicol. Appl. Pharmacol. 258, 256–267 (2012)

4. Storr, M.A., Keenan, C.M., Emmerdinger, D., Zhang, H., Yüce, B., Sibaev, A., Massa, F., Buckley, N.E., Lutz, B., Göke, B., Brand, S., Patel, K.D., Sharkey, K.A.: Targeting endocannabinoid degradation protects against experimental colitis in mice: involve-ment of CB1 and CB2 receptors. J. Mol. Med. (Berl) 86, 925–936 (2008)

5. Andrzejak, V., Muccioli, G.G., Body-Malapel, M., El Bakali, J., Djouina, M., Renault, N., Chavatte, P., Desreumaux, P., Lambert, D.M., Millet, R.: New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis. Bioorg. Med. Chem. 19, 3777–3786 (2011)